(secondQuint)NAM-Trial: Multiferon in Malignant Melanoma.

 The study is an open label, multicenter phase IIa clinical trial which is designed as a pilot project in order to establish the efficacy and tolerability of Multiferon as a neoadjuvant treatment of locoregional metastases.

 Patients will be treated subsequently in cohorts characterized by different doses (3 - 9 - 18 MIU) to analyze dosage dependent effects.

.

 NAM-Trial: Multiferon in Malignant Melanoma@highlight

The current clinical trial shall clarify the efficacy, safety and biologic effects of neoadjuvant treatment with natural interferon- (Multiferon) in patients with locoregional metastases of melanoma in stage IIIB/C.

